Discovery and synthesis of novel substituted benzocoumarins as orally active lipid modulating agents

被引:61
作者
Sashidhara, Koneni V. [1 ]
Kumar, Manoj [1 ]
Modukuri, Ram K. [1 ]
Srivastava, Anuj [2 ]
Puri, Anju [2 ]
机构
[1] Cent Drug Res Inst CSIR CDRI, Med & Proc Chem Div, Lucknow 226001, Uttar Pradesh, India
[2] Cent Drug Res Inst CSIR CDRI, Div Biochem, Lucknow 226001, Uttar Pradesh, India
关键词
Synthesis; Benzocoumarin; Statins; Antidyslipidemic; LOW-DENSITY-LIPOPROTEIN; DERIVATIVES;
D O I
10.1016/j.bmcl.2011.09.053
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis of a series of benzocoumarin keto-enamine schiff bases is reported. The novel compounds were evaluated for their antihyperlipidemic activity in the hyperlipidemic hamster model. The compound 11 at a dose of 10 mg/kg body weight significantly lowered the plasma triglyceride levels (TG) by 70%, total cholesterol (TC) by 47%, accompanied by an increase in HDL-C/TC ratio by 80% in hyperlipidemic hamsters to a greater degree than the reference drugs atorvastatin and lovastatin. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6709 / 6713
页数:5
相关论文
共 16 条
[1]  
Bhatia Gitika, 2003, Indian Journal of Experimental Biology, V41, P1456
[2]   ω-(2-Naphthyloxy) amino alkanes as a novel class of anti-hyperglycemic and lipid lowering agents [J].
Chaturvedi, Devdutt ;
Ray, Suprabhat ;
Srivastava, Arvind K. ;
Chander, Ramesh .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (05) :2489-2498
[3]   The myotoxicity of statins [J].
Evans, M ;
Rees, A .
CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (04) :415-420
[4]   Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs [J].
Graham, DJ ;
Staffa, JA ;
Shatin, D ;
Andrade, SE ;
Schech, SD ;
La Grenade, L ;
Gurwitz, JH ;
Chan, KA ;
Goodman, MJ ;
Platt, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (21) :2585-2590
[5]   THE HYPOLIPIDEMIC ACTIVITY OF ALKYLAMINES AND THEIR BORANE DERIVATIVES - STRUCTURE ACTIVITY RELATIONSHIP IN RODENTS [J].
GRIFFIN, TS ;
DOCKS, EL ;
BROTHERTON, RJ ;
HALL, IH .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1991, 26 (05) :517-527
[6]   Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients [J].
Inoue, T ;
Hayashi, M ;
Takayanagi, K ;
Morooka, S .
ATHEROSCLEROSIS, 2002, 160 (02) :369-376
[7]   Antidyslipidemic action of fenofibrate in dyslipidemic-diabetic hamster model [J].
Rizvi, F ;
Puri, A ;
Bhatia, G ;
Khanna, AK ;
Wulff, EM ;
Rastogi, AK ;
Chander, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 305 (02) :215-222
[8]   THE PATHOGENESIS OF ATHEROSCLEROSIS - A PERSPECTIVE FOR THE 1990S [J].
ROSS, R .
NATURE, 1993, 362 (6423) :801-809
[9]  
RUSSEL RN, 1986, ENGL J MED, V314, P488
[10]   Identification of the antioxidant principles of Polyalthia longifolia var. pendula using TEAC assay [J].
Sashidhara, Koneni V. ;
Singh, Suriya P. ;
Srivastava, Anuj ;
Puri, Anju .
NATURAL PRODUCT RESEARCH, 2011, 25 (09) :918-926